Embotelladora Andina Valuation
Is ANDINA-B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ANDINA-B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ANDINA-B (CLP2840) is trading below our estimate of fair value (CLP3114.23)
Significantly Below Fair Value: ANDINA-B is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ANDINA-B?
Other financial metrics that can be useful for relative valuation.
What is ANDINA-B's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CL$2.28t |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.7x |
Enterprise Value/EBITDA | 4.4x |
PEG Ratio | 3.1x |
Price to Earnings Ratio vs Peers
How does ANDINA-B's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 15.1x | ||
EMBONOR-A Coca-Cola Embonor | 6.5x | n/a | CL$574.2b |
CCU Compañía Cervecerías Unidas | 20.5x | 15.2% | CL$2.2t |
CONCHATORO Viña Concha y Toro | 18x | 18.0% | CL$945.9b |
AQUACHILE Empresas AquaChile | 15.5x | n/a | CL$985.0b |
ANDINA-B Embotelladora Andina | 13.5x | 4.3% | CL$2.3t |
Price-To-Earnings vs Peers: ANDINA-B is good value based on its Price-To-Earnings Ratio (13.5x) compared to the peer average (15.1x).
Price to Earnings Ratio vs Industry
How does ANDINA-B's PE Ratio compare vs other companies in the Global Beverage Industry?
Price-To-Earnings vs Industry: ANDINA-B is good value based on its Price-To-Earnings Ratio (13.5x) compared to the Global Beverage industry average (18.5x).
Price to Earnings Ratio vs Fair Ratio
What is ANDINA-B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13.5x |
Fair PE Ratio | 14.5x |
Price-To-Earnings vs Fair Ratio: ANDINA-B is good value based on its Price-To-Earnings Ratio (13.5x) compared to the estimated Fair Price-To-Earnings Ratio (14.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CL$2,840.00 | CL$2,642.42 -7.0% | 16.8% | CL$3,315.00 | CL$1,900.00 | n/a | 12 |
Apr ’25 | CL$2,495.90 | CL$2,367.58 -5.1% | 12.8% | CL$3,047.00 | CL$1,900.00 | n/a | 12 |
Mar ’25 | CL$2,455.00 | CL$2,367.58 -3.6% | 12.8% | CL$3,047.00 | CL$1,900.00 | n/a | 12 |
Feb ’25 | CL$2,361.00 | CL$2,337.25 -1.0% | 10.6% | CL$2,683.00 | CL$1,900.00 | n/a | 12 |
Jan ’25 | CL$2,190.00 | CL$2,302.25 +5.1% | 12.1% | CL$2,650.00 | CL$1,700.00 | n/a | 12 |
Dec ’24 | CL$2,138.00 | CL$2,270.64 +6.2% | 11.9% | CL$2,550.00 | CL$1,700.00 | n/a | 11 |
Nov ’24 | CL$1,820.00 | CL$2,255.60 +23.9% | 12.1% | CL$2,576.00 | CL$1,700.00 | n/a | 10 |
Oct ’24 | CL$1,999.00 | CL$2,343.80 +17.2% | 9.2% | CL$2,600.00 | CL$1,900.00 | n/a | 10 |
Sep ’24 | CL$2,157.00 | CL$2,343.80 +8.7% | 9.2% | CL$2,600.00 | CL$1,900.00 | n/a | 10 |
Aug ’24 | CL$2,305.00 | CL$2,303.40 -0.07% | 8.9% | CL$2,600.00 | CL$1,900.00 | n/a | 10 |
Jul ’24 | CL$2,101.00 | CL$2,234.80 +6.4% | 7.8% | CL$2,456.00 | CL$1,900.00 | n/a | 10 |
Jun ’24 | CL$2,050.00 | CL$2,234.80 +9.0% | 7.8% | CL$2,456.00 | CL$1,900.00 | n/a | 10 |
May ’24 | CL$2,022.20 | CL$2,156.73 +6.7% | 8.3% | CL$2,400.00 | CL$1,900.00 | CL$2,715.00 | 11 |
Apr ’24 | CL$2,050.00 | CL$2,109.45 +2.9% | 8.3% | CL$2,400.00 | CL$1,882.00 | CL$2,495.90 | 11 |
Mar ’24 | CL$2,060.00 | CL$2,109.45 +2.4% | 8.3% | CL$2,400.00 | CL$1,882.00 | CL$2,455.00 | 11 |
Feb ’24 | CL$2,075.00 | CL$2,118.27 +2.1% | 7.8% | CL$2,400.00 | CL$1,900.00 | CL$2,361.00 | 11 |
Jan ’24 | CL$2,079.90 | CL$2,063.73 -0.8% | 7.9% | CL$2,400.00 | CL$1,900.00 | CL$2,190.00 | 11 |
Dec ’23 | CL$1,800.00 | CL$2,042.92 +13.5% | 8.3% | CL$2,400.00 | CL$1,814.00 | CL$2,138.00 | 12 |
Nov ’23 | CL$1,650.00 | CL$2,072.17 +25.6% | 8.9% | CL$2,400.00 | CL$1,814.00 | CL$1,820.00 | 12 |
Oct ’23 | CL$1,676.10 | CL$2,059.33 +22.9% | 7.1% | CL$2,300.00 | CL$1,850.00 | CL$1,999.00 | 12 |
Sep ’23 | CL$1,834.10 | CL$2,042.67 +11.4% | 6.9% | CL$2,300.00 | CL$1,850.00 | CL$2,157.00 | 12 |
Aug ’23 | CL$1,636.80 | CL$2,049.83 +25.2% | 6.8% | CL$2,300.00 | CL$1,850.00 | CL$2,305.00 | 12 |
Jul ’23 | CL$1,633.00 | CL$2,080.92 +27.4% | 7.0% | CL$2,300.00 | CL$1,900.00 | CL$2,101.00 | 12 |
Jun ’23 | CL$1,675.00 | CL$2,072.58 +23.7% | 6.8% | CL$2,300.00 | CL$1,900.00 | CL$2,050.00 | 12 |
May ’23 | CL$1,550.00 | CL$2,078.17 +34.1% | 6.9% | CL$2,300.00 | CL$1,900.00 | CL$2,022.20 | 12 |
Analyst Forecast: Target price is lower than the current share price.